Biliary Carcinoma Clinical Trial
Official title:
A Randomized, Open, Parallel, Single Center Phase I Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of TQB3454 Tablets in Healthy Adult Subjects.
This is a randomized, open, parallel, single center phase I clinical trial to evaluate the impact of food on the pharmacokinetics of TQB3454 tablets in healthy adult subjects. The aim is to evaluate the impact of food on the pharmacokinetics as well as the safety after single dose of TQB3454 tablets taken orally by Chinese healthy adult subjects, with pharmacokinetic indicators as the primary endpoint.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03609489 -
A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma
|
Phase 2 | |
| Not yet recruiting |
NCT05987358 -
A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
|
Phase 3 | |
| Completed |
NCT01389414 -
Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma
|
Phase 2 | |
| Active, not recruiting |
NCT03225989 -
Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer
|
Phase 1/Phase 2 | |
| Terminated |
NCT01855724 -
Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer
|
Phase 2 | |
| Completed |
NCT02631590 -
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
|
Phase 2 | |
| Recruiting |
NCT05540483 -
RC-48 Combined With GLS-010 in HER2-overexpressed Patients With Previously Treated Unresectable Biliary Tract Cancer
|
N/A |